bluebird bio Inc (NASDAQ:BLUE)

46.03
Delayed Data
As of Jan 26
 -2.03 / -4.22%
Today’s Change
38.95
Today|||52-Week Range
94.50
+6.38%
Year-to-Date
3 Stocks Wall Street Thinks Will Soar 50% or More in 2021
Jan 24 / MotleyFool.com - Paid Partner Content
Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous
Jan 19 / MotleyFool.com - Paid Partner Content
New Strong Sell Stocks for January 21st
Jan 21 / Zacks.com - Paid Partner Content
Harpoon's (HARP) Multiple Myeloma Candidate Gets Orphan Drug Tag
Jan 14 / Zacks.com - Paid Partner Content
Why Verastem Stock Sank Today
Jan 20 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close48.10
Today’s open48.25
Day’s range45.60 - 48.40
Volume1,129,626
Average volume (3 months)1,031,707
Market cap$3.1B
Data as of 4:00pm ET, 01/26/2021

Growth & Valuation

Earnings growth (last year)-33.98%
Earnings growth (this year)+30.84%
Earnings growth (next 5 years)-64.66%
Revenue growth (last year)-18.15%
P/E ratioNM
Price/Sales108.41
Price/Book2.01

Competitors

 Today’s
change
Today’s
% change
NSTGNanoString Technolog...-8.07-10.48%
RCKTRocket Pharmaceutica...-3.35-5.88%
NKTRNektar Therapeutics+0.50+2.82%
XNCRXencor Inc-0.01-0.02%
Data as of 4:00pm ET, 01/26/2021

Financials

Next reporting dateMarch 1, 2021
EPS forecast (this quarter)-$2.95
Annual revenue (last year)$44.7M
Annual profit (last year)-$789.6M
Net profit margin-1,767.49%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts